Literature DB >> 20592090

Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection.

Malin Stoltz1, Jonas Klingström.   

Abstract

Type III interferons ([IFNs] IFN-lambda and interleukin-28 and -29 [IL-28/29]) are recently recognized cytokines with innate antiviral effects similar to those of type I IFNs (IFN-alpha/beta). Like IFN-alpha/beta, IFN-lambda-expression can be induced by viruses, and it is believed that type I and III IFNs are regulated in the same manner. Hantaviruses are weak IFN-alpha/beta inducers and have surprisingly been shown to activate IFN-alpha/beta-independent IFN-stimulated gene (ISG) expression. Here, we show that in Hantaan virus (HTNV)-infected human epithelial A549 cells, induction of IFN-lambda1 preceded induction of MxA and IFN-beta by 12 and 24 h, respectively, and IFN-alpha was not induced at all. Furthermore, induction of IFN-lambda1 and MxA was observed in HTNV-infected African green monkey epithelial Vero E6 cells, a cell line that cannot produce type I IFNs, clearly showing that HTNV can induce IFN-lambda1 and ISGs in the complete absence of IFN-alpha/beta. In HTNV-infected human fibroblast MRC-5 cells, which lack the IFN-lambda receptor, induction of MxA coincided in time with IFN-beta-induction. UV-inactivated HTNV did not induce any IFNs or MxA in any cell line, showing that activation of IFN-lambda1 is dependent on replicating virus. Induction of both IFN-beta and IFN-lambda1 in A549 cells after poly(I:C)-stimulation was strongly inhibited in HTNV-infected cells, suggesting that HTNV can inhibit signaling pathways used to simultaneously activate types I and III IFNs. In conclusion, we show that HTNV can cause type I IFN-independent IFN-lambda1 induction and IFN-lambda1-specific ISG induction. Importantly, the results suggest the existence of specific signaling pathways that induce IFN-lambda1 without simultaneous type I IFN induction during virus infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592090      PMCID: PMC2937636          DOI: 10.1128/JVI.00717-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity.

Authors:  Matthew P Morrow; Panyupa Pankhong; Dominick J Laddy; Kimberly A Schoenly; Jian Yan; Neil Cisper; David B Weiner
Journal:  Blood       Date:  2009-03-20       Impact factor: 22.113

2.  The role of transposable elements in the regulation of IFN-lambda1 gene expression.

Authors:  Scott J P Thomson; Fui G Goh; Helen Banks; Thomas Krausgruber; Sergei V Kotenko; Brian M J Foxwell; Irina A Udalova
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

3.  Hantaan virus triggers TLR3-dependent innate immune responses.

Authors:  Wiebke Handke; Robin Oelschlegel; Renate Franke; Detlev H Krüger; Andreas Rang
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells.

Authors:  Jihong Dai; Nicholas J Megjugorac; Grant E Gallagher; Raymond Y L Yu; Grant Gallagher
Journal:  Blood       Date:  2009-04-03       Impact factor: 22.113

5.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Authors:  Dongliang Ge; Jacques Fellay; Alexander J Thompson; Jason S Simon; Kevin V Shianna; Thomas J Urban; Erin L Heinzen; Ping Qiu; Arthur H Bertelsen; Andrew J Muir; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

6.  Hantaan virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B.

Authors:  Shannon L Taylor; Natalia Frias-Staheli; Adolfo García-Sastre; Connie S Schmaljohn
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

7.  Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Authors:  Yasuhito Tanaka; Nao Nishida; Masaya Sugiyama; Masayuki Kurosaki; Kentaro Matsuura; Naoya Sakamoto; Mina Nakagawa; Masaaki Korenaga; Keisuke Hino; Shuhei Hige; Yoshito Ito; Eiji Mita; Eiji Tanaka; Satoshi Mochida; Yoshikazu Murawaki; Masao Honda; Akito Sakai; Yoichi Hiasa; Shuhei Nishiguchi; Asako Koike; Isao Sakaida; Masatoshi Imamura; Kiyoaki Ito; Koji Yano; Naohiko Masaki; Fuminaka Sugauchi; Namiki Izumi; Katsushi Tokunaga; Masashi Mizokami
Journal:  Nat Genet       Date:  2009-09-13       Impact factor: 38.330

8.  IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.

Authors:  Vijayaprakash Suppiah; Max Moldovan; Golo Ahlenstiel; Thomas Berg; Martin Weltman; Maria Lorena Abate; Margaret Bassendine; Ulrich Spengler; Gregory J Dore; Elizabeth Powell; Stephen Riordan; David Sheridan; Antonina Smedile; Vincenzo Fragomeli; Tobias Müller; Melanie Bahlo; Graeme J Stewart; David R Booth; Jacob George
Journal:  Nat Genet       Date:  2009-09-13       Impact factor: 38.330

Review 9.  Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses.

Authors:  Mingcai Li; Xiaojin Liu; Yanchun Zhou; Shao Bo Su
Journal:  J Leukoc Biol       Date:  2009-04-30       Impact factor: 4.962

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  35 in total

1.  Sangassou virus, the first hantavirus isolate from Africa, displays genetic and functional properties distinct from those of other murinae-associated hantaviruses.

Authors:  Boris Klempa; Peter T Witkowski; Elena Popugaeva; Brita Auste; Lamine Koivogui; Elisabeth Fichet-Calvet; Thomas Strecker; Jan Ter Meulen; Detlev H Krüger
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.

Authors:  Rémi Villenave; Lindsay Broadbent; Isobel Douglas; Jeremy D Lyons; Peter V Coyle; Michael N Teng; Ralph A Tripp; Liam G Heaney; Michael D Shields; Ultan F Power
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

3.  Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells.

Authors:  Zhiwei Yin; Jihong Dai; Jing Deng; Faruk Sheikh; Mahwish Natalia; Tiffany Shih; Anita Lewis-Antes; Sheela B Amrute; Ursula Garrigues; Sean Doyle; Raymond P Donnelly; Sergei V Kotenko; Patricia Fitzgerald-Bocarsly
Journal:  J Immunol       Date:  2012-08-13       Impact factor: 5.422

4.  Puumala and Andes Orthohantaviruses Cause Transient Protein Kinase R-Dependent Formation of Stress Granules.

Authors:  Wanda Christ; Janne Tynell; Jonas Klingström
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

Review 5.  IFN-λs.

Authors:  Sergei V Kotenko
Journal:  Curr Opin Immunol       Date:  2011-08-15       Impact factor: 7.486

6.  Characterization of two substrains of Puumala virus that show phenotypes that are different from each other and from the original strain.

Authors:  Karin B Sundström; Malin Stoltz; Nina Lagerqvist; Åke Lundkvist; Kirill Nemirov; Jonas Klingström
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

7.  Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling.

Authors:  Michaela Weber; Ali Gawanbacht; Matthias Habjan; Andreas Rang; Christoph Borner; Anna Mareike Schmidt; Sophie Veitinger; Ralf Jacob; Stéphanie Devignot; Georg Kochs; Adolfo García-Sastre; Friedemann Weber
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

8.  Cytokine and chemokine responses of lung exposed to surrogate viral and bacterial infections.

Authors:  Teresa A Liberati; Rita A Trammell; Michelle Randle; Sarah Barrett; Linda A Toth
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

9.  Hantaviruses induce antiviral and pro-inflammatory innate immune responses in astrocytic cells and the brain.

Authors:  Ok Sarah Shin; Gabriella Shinyoung Song; Mukesh Kumar; Richard Yanagihara; Ho-Wang Lee; Jin-Won Song
Journal:  Viral Immunol       Date:  2014-06-17       Impact factor: 2.257

10.  Using barcoded Zika virus to assess virus population structure in vitro and in Aedes aegypti mosquitoes.

Authors:  James Weger-Lucarelli; Selene M Garcia; Claudia Rückert; Alex Byas; Shelby L O'Connor; Matthew T Aliota; Thomas C Friedrich; David H O'Connor; Gregory D Ebel
Journal:  Virology       Date:  2018-06-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.